On October 4, 2026, Profusa entered into amendments with Ascent Partners Fund LLC regarding Senior Secured Convertible Promissory Notes issued in April 2026. The amendments revise the conversion price mechanism to the greater of $1.20 or 95% of the five-day VWAP, establishing a fixed floor price of $0.338 per share. Ascent also waived anti-dilution provisions for three additional notes issued in August and September 2026. Profusa operates in the biotechnology sector, developing photobiomodulation therapies.
